Chewy, Inc. 10-Q Summary: Quarter Ended July 28, 2024
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Chewy, Inc., the largest pet e-tailer in the United States, for the 13-week period ended July 28, 2024. The company operates an e-commerce platform offering pet food, supplies, and healthcare products, heavily utilizing its Autoship subscription program. The fiscal year 2024 is a 53-week year ending February 2, 2025.
Key Financial Metrics
| Metric | 13 Weeks Ended July 28, 2024 | 26 Weeks Ended July 28, 2024 |
|---|---|---|
| Net Sales | $2.86 billion | $5.74 billion |
| Gross Profit | $843.8 million (29.5% margin) | $1.70 billion (29.6% margin) |
| Net Income | $299.1 million ($0.68 diluted EPS) | $366.0 million ($0.84 diluted EPS) |
| Adjusted EBITDA | $144.8 million (5.1% margin) | $307.8 million (5.4% margin) |
| Operating Cash Flow | $123.4 million | $205.3 million |
| Free Cash Flow | $91.5 million | $144.1 million |
| Cash & Equivalents | $694.5 million (as of July 28, 2024) | N/A |
| Debt | $0 outstanding borrowings | N/A |
Liquidity: The company holds $694.5 million in cash and cash equivalents and has $760.2 million of borrowing capacity available under its $800 million ABL Credit Facility, with no outstanding borrowings as of the reporting date.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2.6% year-over-year (YoY) for the quarter and 2.9% for the year-to-date (YTD), driven by higher spending per active customer (+6.2%) despite a slight decline in total active customers (-1.8%).
- Profitability Surge: Net income jumped from $20.2 million in the prior year quarter to $299.1 million. This was primarily driven by a one-time $275.7 million income tax benefit resulting from the release of a valuation allowance on deferred tax assets.
- Margin Expansion: Gross margin expanded by 120 basis points YoY to 29.5%, attributed to efficiency gains in the fulfillment network and margin expansion in healthcare and private brands.
- Share Repurchases: The company executed a significant $500 million share repurchase agreement with an affiliate (Buddy Chester Sub LLC) in June 2024, retiring 17.55 million shares. Total repurchases for the quarter were approximately $532.7 million.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted strong performance in healthcare and specialty businesses. They noted that while macroeconomic conditions (inflation, interest rates) remain a factor, the company is adapting logistics and supply chain processes to meet customer needs. The company continues to invest in marketing to drive customer acquisition and retention, particularly with expansion into Canada.
Forward-Looking Statements: The filing contains standard forward-looking statements regarding growth rates, margin improvement, and capital allocation. Management does not provide specific numerical guidance for future quarters in this text but emphasizes the ability to sustain growth and manage costs.
Risks and Contingencies:
- Macroeconomic Environment: Risks related to inflation and consumer spending behavior.
- Competition: Intense competition in the pet products and e-commerce sectors.
- Supply Chain: Potential disruptions in shipping and fulfillment operations.
- Legal: Various legal claims arise in the normal course of business, though management does not believe they will have a material adverse effect.
Investor Verification Checklist
- Tax Benefit Sustainability: Verify the nature of the $275.7 million tax benefit (release of valuation allowance) to understand its non-recurring impact on net income and EPS.
- Share Repurchase Impact: Confirm the remaining authorized amount under the $500 million repurchase program ($467.3 million remaining) and the impact of the $500 million affiliate buyback on capital structure.
- Customer Metrics: Monitor the trend of "Active Customers" which declined 1.8% YoY, contrasting with the increase in sales per customer, to assess long-term growth drivers.
- Working Capital: Review the $90 million cash decrease from working capital changes, specifically the increase in inventories and receivables.
- Non-GAAP Reconciliations: Cross-reference Adjusted EBITDA and Adjusted Net Income with GAAP figures to isolate the impact of share-based compensation and other non-cash items.